Y70 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.
Rabeprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y70
Rabeprazole Sodium Delayed-Release
- Imprint:
- Y70
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma Limited
- National Drug Code (NDC):
- 65862-0721
More about rabeprazole
- Rabeprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 58 Reviews
- Drug class: proton pump inhibitors
Consumer resources
- Rabeprazole
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)
Other brands: Aciphex, Aciphex Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
